Company intelligence / Profile preview
Tilray
New York City, New York, United Statestilray.com ↗
- Ownership
- Public · TLRY
- Employees
- ~330
- Development stage
- Commercial
01
Overview
Tilray has established itself as a global leader in medical cannabis with commercial operations across North America and Europe. The company was the first to conduct a Health Canada-approved clinical trial for medical cannabis in Canada and remains the leading provider of medical cannabis extracts in Germany. It continues to expand its portfolio with new high-potency formulations and premium flower genetics for patients requiring advanced cannabinoid therapies. Recent launches include German-grown GMP-certified flowers under new cultivation licenses.
- Therapeutic areas
- OncologyPsychiatryNeurology
- Modalities
- Plant-derived therapy (medical cannabis flower and extracts)Small molecule (cannabinoids THC and CBD are small molecules)Biologic (for some GMP-certified products derived from plant material)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Sandoz/Novartis subsidiary for co-branded non-smokeable/non-combustible products globallydistribution partnerships across Europe
04
Financials
- Market cap
- $314.2M
- Total revenue
- $915.5M
- Enterprise value
- $468.2M
Beyond the preview
Go deeper on Tilray.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tilray.